A Moderna experimental vaccine tailored to each patient's tumor cut odds of deadly skin cancer returning — and new five-year data shows the results holding.
This article was originally published by 9News Colorado (RSS) on Monday, June 1, 2026. TownPost surfaces local news from over 40 outlets and uses AI to score each story for relevance to Longmont and the surrounding area.
Relevance score: 30/100. This story has regional context that may affect Longmont.
TownPost does not modify or rewrite source content. Read the full article at its original publication for complete coverage.
